$KPTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Karyopharm Therapeutics Inc.. Get notifications about new insider transactions in Karyopharm Therapeutics Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 09 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.61 | 2,800 | 52,098 | 8,329,737 | 8.3 M to 8.3 M (-0.03 %) |
| Aug 09 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.60 | 10,602 | 197,197 | 8,332,537 | 8.3 M to 8.3 M (-0.13 %) |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 14,264 | |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.04 | 12,500 | 225,556 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 12,500 | 413 | 14,264 | |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.04 | 12,500 | 225,556 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Jul 25 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.52 | 895 | 16,571 | 8,343,139 | 8.3 M to 8.3 M (-0.01 %) |
| Jul 25 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.63 | 9,144 | 170,342 | 8,344,034 | 8.4 M to 8.3 M (-0.11 %) |
| Jul 25 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.66 | 20,000 | 373,222 | 8,353,178 | 8.4 M to 8.4 M (-0.24 %) |
| Jul 23 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 19.21 | 26,742 | 513,805 | 8,373,178 | 8.4 M to 8.4 M (-0.32 %) |
| Jul 23 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.90 | 100,000 | 1,889,940 | 8,399,920 | 8.5 M to 8.4 M (-1.18 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 4,242 | 20,158 | 476,061 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 5,757 | 1,520 | 0 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 1 | 0 | 0 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.27 | 10,000 | 182,686 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 4,242 | 20,158 | 522,143 | 517.9 K to 522.1 K (+0.82 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 5,757 | 1,520 | 517,901 | 512.1 K to 517.9 K (+1.12 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 1 | 0 | 512,144 | 512.1 K to 512.1 K (0.00 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 4,242 | 20,158 | 476,061 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 5,757 | 1,520 | 0 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1 | 0 | 0 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.27 | 10,000 | 182,686 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 4,242 | 20,158 | 522,143 | 517.9 K to 522.1 K (+0.82 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 5,757 | 1,520 | 517,901 | 512.1 K to 517.9 K (+1.12 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1 | 0 | 512,144 | 512.1 K to 512.1 K (0.00 %) |
| Jul 18 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.53 | 30,000 | 556,005 | 8,499,920 | 8.5 M to 8.5 M (-0.35 %) |
| Jul 18 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.50 | 17,346 | 320,901 | 8,529,920 | 8.5 M to 8.5 M (-0.20 %) |
| Jul 18 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.52 | 2,654 | 49,161 | 8,547,266 | 8.5 M to 8.5 M (-0.03 %) |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 26,764 | |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.72 | 12,500 | 233,990 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 12,500 | 413 | 26,764 | |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.72 | 12,500 | 233,990 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Jun 25 2018 | KPTI | Karyopharm Therape ... | Varadan Anand | EVP, Chief Commerci ... | Option Exercise | A | 18.68 | 150,000 | 2,802,000 | 150,000 | |
| Jun 20 2018 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 18.80 | 17,000 | 319,600 | 17,000 | |
| Jun 20 2018 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 18.80 | 17,000 | 319,600 | 17,000 | |
| Jun 20 2018 | KPTI | Karyopharm Therape ... | Garland J. Scott | Director | Option Exercise | A | 18.80 | 17,000 | 319,600 | 17,000 | |
| Jun 20 2018 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 18.80 | 17,000 | 319,600 | 17,000 | |
| Jun 20 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 18.80 | 17,000 | 319,600 | 17,000 | |
| Jun 20 2018 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 18.80 | 17,000 | 319,600 | 17,000 | |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 5,757 | |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.66 | 10,000 | 186,558 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 5,757 | |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.66 | 10,000 | 186,558 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 303 | 10 | 7,553 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 9,697 | 2,560 | 0 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 17.30 | 10,000 | 172,991 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 303 | 10 | 723,510 | 723.2 K to 723.5 K (+0.04 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 9,697 | 2,560 | 723,207 | 713.5 K to 723.2 K (+1.36 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 303 | 10 | 7,553 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 9,697 | 2,560 | 0 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 17.30 | 10,000 | 172,991 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 303 | 10 | 723,510 | 723.2 K to 723.5 K (+0.04 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 9,697 | 2,560 | 723,207 | 713.5 K to 723.2 K (+1.36 %) |
| May 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 15,757 | |
| May 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.39 | 10,000 | 193,870 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| May 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| May 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 15,757 | |
| May 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.39 | 10,000 | 193,870 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| May 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| May 11 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 1.49 | 1,325 | 1,968 | 4,736 | |
| May 11 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 675 | 178 | 0 | |
| May 11 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 18.00 | 2,000 | 36,000 | 0 | 2 K to 0 (-100.00 %) |
| May 11 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 1.49 | 1,325 | 1,968 | 1,325 | 0 to 1.3 K |
| May 11 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 675 | 178 | 675 | 0 to 675 |
| May 10 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 18.01 | 2,000 | 36,024 | 2,881 | 4.9 K to 2.9 K (-40.98 %) |
| May 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 9,697 | |
| May 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.77 | 10,000 | 167,747 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| May 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| May 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 9,697 | |
| May 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.77 | 10,000 | 167,747 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| May 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 7,576 | 2,000 | 18,181 | |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 2,424 | 640 | 0 | |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.79 | 10,000 | 147,878 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 7,576 | 2,000 | 18,181 | |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 2,424 | 640 | 0 | |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.79 | 10,000 | 147,878 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 19,697 | |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.48 | 10,000 | 124,829 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 19,697 | |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.48 | 10,000 | 124,829 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 2,424 | |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 15.29 | 10,000 | 152,895 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 2,424 | |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.29 | 10,000 | 152,895 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Mar 14 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 2,500 | 660 | 675 | |
| Mar 14 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 17.01 | 2,500 | 42,525 | 0 | 2.5 K to 0 (-100.00 %) |
| Mar 14 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 2,500 | 660 | 2,500 | 0 to 2.5 K |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 606 | 160 | 29,697 | |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 9,394 | 2,480 | 0 | |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.15 | 10,000 | 161,463 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 606 | 160 | 29,697 | |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 9,394 | 2,480 | 0 | |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.15 | 10,000 | 161,463 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Mar 06 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 2,500 | 660 | 3,175 | |
| Mar 06 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 16.00 | 2,500 | 40,000 | 0 | 2.5 K to 0 (-100.00 %) |
| Mar 06 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 2,500 | 660 | 2,500 | 0 to 2.5 K |
| Mar 06 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.03 | 2,500 | 40,076 | 4,881 | 7.4 K to 4.9 K (-33.87 %) |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 12,424 | |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.79 | 10,000 | 147,872 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 12,424 | |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.79 | 10,000 | 147,872 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Feb 20 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 15.01 | 1,486 | 22,298 | 7,381 | 8.9 K to 7.4 K (-16.76 %) |
| Feb 20 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 15.02 | 1,014 | 15,229 | 8,867 | 9.9 K to 8.9 K (-10.26 %) |
| Feb 12 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 1,500 | 396 | 5,675 | |
| Feb 12 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 14.00 | 1,500 | 21,000 | 0 | 1.5 K to 0 (-100.00 %) |
| Feb 12 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 1,500 | 396 | 1,500 | 0 to 1.5 K |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 401 | 106 | 7,175 | |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 1,099 | 290 | 0 | |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 13.00 | 1,500 | 19,500 | 0 | 1.5 K to 0 (-100.00 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 401 | 106 | 1,500 | 1.1 K to 1.5 K (+36.49 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 1,099 | 290 | 1,099 | 0 to 1.1 K |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 13.00 | 1,500 | 19,500 | 9,881 | 11.4 K to 9.9 K (-13.18 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 9,394 | |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.50 | 10,000 | 125,048 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 10.45 | 60,000 | 627,000 | 60,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | FALVEY MICHAEL | EVP, CFO & Treasure ... | Option Exercise | A | 10.45 | 95,000 | 992,750 | 95,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | A | 10.45 | 125,000 | 1,306,250 | 125,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 10.45 | 200,000 | 2,090,000 | 200,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 10.45 | 200,000 | 2,090,000 | 200,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.45 | 200,000 | 2,090,000 | 200,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.45 | 200,000 | 2,090,000 | 200,000 | |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 22,424 | |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 10.09 | 10,000 | 100,882 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 22,424 | |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.09 | 10,000 | 100,882 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 19,394 | |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.08 | 10,000 | 100,769 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 19,394 | |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 10.08 | 10,000 | 100,769 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |